Anti-CD123 Antibody, Biotin-Labeled

Only %1 left
Catalog #
101733
As low as $210 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

This anti-CD123 antibody is a purified, recombinant human monoclonal antibody that recognizes human CD123. This construct contains an Avi-tag™ in the middle of the Heavy Chain constant region. This recombinant antibody has been tested for specific binding to purified recombinant human CD123 by ELISA.

Synonyms
Translation initiation factor eIF2 assembly protein, C10orf7, D123, Cell division cycle protein 123 homolog (Protein D123), HT-1080, PZ32
Product Info
Storage and Usage
Citations
Species
Human
Isotype
IgG1
Clonality
Monoclonal
Host Species/Expression System
HEK293
Purity

≥90%

Format

Aqueous buffer solution.

Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

MW
Heavy Chain: 52 kDa; Light Chain: 24 kDa + glycans
Glycosylation
This antibody runs at a higher MW by SDS-PAGE due to glycosylation.
UniProt #
O75794
Label

This antibody is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation is confirmed to be >90%.

For more information on enzymatic biotinylation, please see our Tech Note

Background

CD123, also known as interleukin 3 receptor alpha (IL3Ra), is a transmembrane protein found in pluripotent progenitor cells and involved in hematopoietic lineage differentiation. It can also be found in basophils, plasmacytoid dendritic cells and dendritic cells. CD123 is overexpressed on leukemic hematopoietic stem cells (HSCs), but not normal HSCs. It has been found in acute myeloid and B-lymphoid leukemias, blastic plasmacytoid dendritic neoplasms (BPDCN) and hairy cell leukemia. This expression profile makes CD123 an attractive target in cancer therapy. CAR-Ts and other therapies targeting CD123 are currently being evaluated in clinical trials.